https://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.png00qcbofficehttps://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.pngqcboffice2021-10-13 14:33:302022-01-19 09:21:47Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease
https://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.png00qcbofficehttps://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.pngqcboffice2021-10-13 14:28:532021-12-10 08:14:31Validation of an internationally derived patient severity phenotype to support COVID-19 analytics from electronic health record data
https://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.png00qcbofficehttps://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.pngqcboffice2021-10-13 14:26:272022-01-19 09:17:14Reducing Emergency Department Visits Among Patients With Diabetes by Embedding Clinical Pharmacists in the Primary Care Teams
https://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.png00qcbofficehttps://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.pngqcboffice2021-10-13 14:15:112021-10-13 14:15:11PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development
https://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.png00qcbofficehttps://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.pngqcboffice2021-10-13 14:13:232021-10-13 14:13:23An in vitro quantitative systems pharmacology approach for deconvolving mechanisms of drug-induced, multilineage cytopenias
https://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.png00qcbofficehttps://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.pngqcboffice2021-10-13 14:11:162021-10-13 14:11:16PathFXweb: a web application for identifying drug safety and efficacy phenotypes
https://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.png00qcbofficehttps://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.pngqcboffice2021-10-13 14:08:302021-10-13 14:08:30Scientific considerations for global drug development
https://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.png00qcbofficehttps://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.pngqcboffice2021-10-13 14:00:092021-10-13 14:00:09Sex-specific I KAS activation in rabbit ventricles with drug-induced QT prolongation
https://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.png00qcbofficehttps://qcb.ucla.edu/wp-content/uploads/sites/14/2024/04/Uxd_Blk_QuantitativeComputationalBios_D.pngqcboffice2021-10-13 13:58:302021-10-13 13:58:30Simultaneous activation of the small conductance calcium-activated potassium current by acetylcholine and inhibition of sodium current by ajmaline cause J-wave syndrome in Langendorff-perfused rabbit ventricles
